|
US2020261477A1
|
|
Treatment of airway disorders and cough
|
|
US2020171058A1
|
|
Treatment of upper aerodigestive tract disorders and cough
|
|
US2019105335A1
|
|
Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
|
|
US2017136045A1
|
|
Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
|
|
US2017240575A1
|
|
Chemical inhibitors of sebocyte function
|
|
US2015265752A1
|
|
Topical agents for the treatment of sensory discomfort in the nasal cavity
|
|
US2015105349A1
|
|
(R)-(-)-1,2-propanediol compositions and methods
|
|
US2012251461A1
|
|
[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
|
|
US2012053152A1
|
|
(R)-(-)-1,2-propanediol compositions and methods
|
|
EP2234613A1
|
|
P-menthawe-3-carboxylic acid esters to treat airways diseases
|
|
EP2079681A1
|
|
N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use
|
|
US2007155755A1
|
|
N-arylshydroxyalkylidene-carboxamide compositions and methods
|
|
US7417048B2
|
|
Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets
|
|
US7169377B2
|
|
Radioligands for the TRP-M8 receptor and methods therewith
|
|
US5916878A
|
|
γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
|
|
WO9719691A1
|
|
Gamma-l-glutamyl containing immunomodulator compounds and methods therewith
|
|
US5744452A
|
|
γ-L-glutamyl containing immunomodulator compounds and methods therewith
|
